Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Strides Pharma hits record high as arm gets USFDA nod for asthma drug

Strides Pharma Science advanced 2.12% to Rs 1,372.45 after its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore, received US Food & Drug Administration (USFDA) approval for Theophylline Extended-Release tablets.

By: business-standard.com

Sep 06 2024
0
0 Views

Strides Pharma hits record high as arm gets USFDA nod for asthma drug

Strides Pharma hits record high as arm gets USFDA nod for asthma drug

Related

Strides Pharma hits record high as arm gets USFDA nod for asthma drug

Volumes spurt at Indigo Paints Ltd counter

VA TECH WABAG soars after bagging contract worth $317 million from Saudi Water Authority

Performance of regulatory bodies, railway subsidies under PAC scanner

How to trade Max Financial Services stock amid these 3 key developments

Here's why Sensex fell 950 pts, Nifty slipped below 24,900 intraday today

Vodafone Idea share price tanks 14% to hit 3-month low: Check why

MeitY urges swift removal of fake content by intermediaries after HC order

Matrimony.com board OKs Rs 72-cr share buyback

Sensex slumps 853 pts; oil & gas shares slides for 4th day

Investors lose Rs 4.12 trillion during morning trade as markets slump

US equities mixed ahead of jobs report

Volumes spurt at Indigo Paints Ltd counter